FDA revises authorizations for 2 Covid-19 monoclonal antibody treatments

In a recent move the FDA revised the authorizations for two monoclonal antibody treatments used to treat COVID-19.

Related Keywords

Alabama ,United States ,Karen Landers ,Steven Werdehoff ,Alabama Department Of Public Health ,Huntsville Hospital ,Alabama Department ,Synergy Wellness ,News ,Coronavirus ,Untsville ,Op Stories ,